Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 19,984 | 25,747 | 80,953 | 60,400 | 45,506 |
Marketable Securities | 214 | 15,734 | 30,105 | 27,070 | 62,193 |
Receivables | 40,663 | 47,820 | 30,717 | 45,358 | 34,351 |
Inventories | 26,004 | 27,102 | 25,143 | 28,670 | 22,581 |
Income taxes - deferred | 3,779 | 7,533 | 4,708 | 4,073 | 4,931 |
TOTAL | $100,560 | $134,046 | $180,464 | $174,515 | $175,260 |
Non-Current Assets | |||||
PPE Net | 149,796 | 163,212 | 166,746 | 167,502 | 158,028 |
Investments And Advances | 956 | 956 | 956 | 956 | 956 |
Intangibles | 2,976 | 20,640 | 20,012 | 42,290 | 48,807 |
Other Non-Current Assets | 8,779 | 6,252 | 5,514 | 5,421 | 3,603 |
TOTAL | $162,507 | $191,060 | $193,228 | $216,169 | $211,394 |
Total Assets | $263,067 | $325,106 | $373,692 | $390,684 | $386,654 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 2,839 | 1,475 | 270 | 260 | 9,900 |
Accounts payable and accrued liabilities | 20,424 | 24,718 | 15,277 | 16,480 | 13,562 |
Accrued Expenses | 4,167 | 4,563 | 3,309 | 6,584 | 4,196 |
Other current liabilities | 4,082 | 9,798 | N/A | N/A | N/A |
TOTAL | $37,976 | $54,637 | $30,734 | $33,822 | $36,369 |
Non-Current Liabilities | |||||
Long Term Debt | 3,003 | 11,737 | 13,212 | 13,482 | 4,080 |
Deferred Revenues | 6,464 | 14,083 | 10,777 | 7,300 | 6,922 |
Other Non-Current Liabilities | 10,635 | 9,275 | 6,636 | 6,402 | 191 |
TOTAL | $18,657 | $26,726 | $28,345 | $30,182 | $15,717 |
Total Liabilities | $56,633 | $81,363 | $59,079 | $64,004 | $52,086 |
Shareholders' Equity | |||||
Shares Outstanding, K | 30,772 | 30,330 | 31,673 | 31,490 | 32,616 |
Common Shares | 360 | 357 | 355 | 353 | 351 |
Retained earnings | 78,954 | 111,250 | 174,121 | 190,816 | 170,256 |
Other shareholders' equity | -11,954 | -4,828 | -4,530 | -6,509 | 4,976 |
TOTAL | $206,434 | $243,743 | $314,613 | $326,680 | $334,568 |
Total Liabilities And Equity | $263,067 | $325,106 | $373,692 | $390,684 | $386,654 |